The injected medication, liraglutide, is under review by the FDA to treat type 2 diabetes. In a study, three-quarters of patients on high doses of the drug lost 5% or more of their body weight.
Read »The injected medication, liraglutide, is under review by the FDA to treat type 2 diabetes. In a study, three-quarters of patients on high doses of the drug lost 5% or more of their body weight.
Read »